DocDollars

Dexcom, Inc.

CA · United States · Reporting entity ID 100000010478

Total reported 2019–2025
$86.1M
#111 of 2,960 reporting companies — 0.1% of all reported industry payments
$18.7M in general payments across 247,400 records, plus $67.4M in research funding across 3,546 records.

How it breaks down

General payments $18,665,926
Research funding $67,421,249

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Dexcom, Inc. reported $86.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #111 of 2,960 reporting companies. 78% of that was research funding and 22% general payments such as consulting, speaking, food and travel. 247,400 general payment records and 3,546 research records were filed.

Common questions about Dexcom, Inc.

How much has Dexcom, Inc. paid US doctors?

Dexcom, Inc. reported $86,087,174 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $18,665,926 in general payments, $67,421,249 in research funding.

How does Dexcom, Inc. rank among drug and device companies?

It ranks #111 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Dexcom, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.